A study comparing effects of leuprolide acetate single depot subcutaneous (7.5 mg) and leuprolide acetate intramuscular microsphere (7.5 mg) in healthy subjects

Trial Profile

A study comparing effects of leuprolide acetate single depot subcutaneous (7.5 mg) and leuprolide acetate intramuscular microsphere (7.5 mg) in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Leuprorelin (Primary) ; Leuprorelin (Primary)
  • Indications Precocious puberty; Prostate cancer
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 18 Feb 2017 Results presented at the 2017 Genitourinary Cancers Symposium
    • 29 Jul 2015 New trial record
    • 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top